Unique Pulmonary Hypertensive Vascular Diseases Associated with Heart and Lung Developmental Defects
Journal of Cardiovascular Development and Disease · 03.08.2023 · 10 (8) · 333
DOI: 10.3390/jcdd10080333 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 03.08.2023. Verfasst von Hidekazu Ishida und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita 565-0871, Osaka, Japan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, JSPS KAKENHI.
Abstract (Originalsprache)
Although pediatric pulmonary hypertension (PH) shares features and mechanisms with adult PH, there are also some significant differences between the two conditions. Segmental PH is a unique pediatric subtype of PH with unclear and/or multifactorial pathophysiological mechanisms, and is often associated with complex congenital heart disease (CHD), pulmonary atresia with ventricular septal defect, and aortopulmonary collateral arteries. Some cases of complex CHD, associated with a single ventricle after Fontan operation, show pathological changes in the small peripheral pulmonary arteries and pulmonary vascular resistance similar to those observed in pulmonary arterial hypertension (PAH). This condition is termed as the pediatric pulmonary hypertensive vascular disease (PPHVD). Recent advances in genetics have identified the genes responsible for PAH associated with developmental defects of the heart and lungs, such as TBX4 and SOX17. Targeted therapies for PAH have been developed; however, their effects on PH associated with developmental heart and lung defects remain to be established. Real-world data analyses on the anatomy, pathophysiology, genetics, and molecular biology of unique PPHVD cases associated with developmental defects of the heart and lungs, using nationwide and/or international registries, should be conducted in order to improve the treatments and prognosis of patients with these types of pediatric PH.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita 565-0871, Osaka, Japan.
- Department of Cardiology, Tokyo Metropolitan Children's Medical Center, 2-8-29 Musashidai, Fuchu 183-8561, Tokyo, Japan.
- Department of Pediatrics, Keio University of Medicine, 35 Shinanomachi, Shinjuku-ku 160-8582, Tokyo, Japan.
- Keio University Health Center, 4-1-1 Hiyoshi, Kohoku-ku, Yokohama 223-8521, Kanagawa, Japan.
ORCID-Profile: Hidekazu Ishida, Jun Maeda, Keiko Uchida
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- JSPS KAKENHI
Zitieren
APA
Ishida, H., Maeda, J., Uchida, K., & Yamagishi, H. (2023). Unique Pulmonary Hypertensive Vascular Diseases Associated with Heart and Lung Developmental Defects. Journal of Cardiovascular Development and Disease, 10(8), 333. https://doi.org/10.3390/jcdd10080333
Vancouver
Ishida H, Maeda J, Uchida K, Yamagishi H. Unique Pulmonary Hypertensive Vascular Diseases Associated with Heart and Lung Developmental Defects. Journal of Cardiovascular Development and Disease. 2023;10(8):333. doi:10.3390/jcdd10080333
BibTeX
@article{Ishida2023,
author = {Ishida, Hidekazu and Maeda, Jun and Uchida, Keiko and Yamagishi, Hiroyuki},
title = {Unique Pulmonary Hypertensive Vascular Diseases Associated with Heart and Lung Developmental Defects},
journal = {Journal of Cardiovascular Development and Disease},
year = {2023},
volume = {10},
number = {8},
pages = {333},
doi = {10.3390/jcdd10080333}
}
EUVIMED